Today: 20 May 2026
Netflix stock slides below $90 as Goldman trims target and Warner bid fight drags on

Netflix stock slides below $90 as Goldman trims target and Warner bid fight drags on

NEW YORK, Jan 9, 2026, 11:05 EST — Regular session

  • Netflix shares fall in late morning trade after Goldman Sachs cuts its price target
  • Paramount keeps up pressure with a rival Warner Bros. bid, keeping deal risk in focus
  • Investors look to Netflix’s Jan. 20 results for clearer financing and guidance signals

Netflix stock fell about 2% on Friday after Goldman Sachs lowered its price target, keeping pressure on a share price already down sharply since the last earnings report. Netflix was down $1.84 at $88.70 in late morning trade, after slipping below $90 and touching a session low of $88.33.

The timing matters because the stock has become a proxy for merger risk, not just streaming fundamentals. Paramount Skydance reiterated on Thursday that its $30-per-share offer for Warner Bros. Discovery tops Netflix’s $27.75-a-share cash-and-stock deal for Warner’s studios and streaming assets, and argued the cable-network spinoff embedded in the Netflix structure could be worth “less than nothing.” Paramount’s tender offer expires on Jan. 21, while Warner has said it would owe Netflix a $2.8 billion termination fee — a breakup payment — if it walks away. Reuters

Netflix also lagged a broader market that was firmer after data showed U.S. job growth slowed in December, keeping bets on rate cuts alive. Wall Street’s main indexes edged higher after nonfarm payrolls rose 50,000, below forecasts, and the unemployment rate dipped to 4.4%, Reuters reported.

Warner’s board has repeatedly pushed back on Paramount’s approach, calling the debt-heavy structure too risky, while some shareholders have urged it to engage. “At the moment, Paramount has a superior bid,” investor Mario Gabelli told Reuters, adding: “Netflix has to simplify their bid.” Reuters

For Netflix investors, the near-term question is whether management can keep the focus on core growth while the Warner situation stays unresolved. Traders will be listening for updates on advertising momentum, live programming economics and cash generation, alongside any hints on how Netflix would finance and integrate a deal of that size.

But the downside case is not subtle. A higher bid for Warner’s assets could force Netflix to pay up or step aside, and regulators could slow the process or demand asset sales, stretching the timeline and keeping the stock under a cloud.

Netflix has said it will post fourth-quarter results and its outlook on Tuesday, Jan. 20 at about 1:01 p.m. Pacific time, with a live video interview featuring co-CEOs Ted Sarandos and Greg Peters and finance executives later that afternoon. That report is the next clear catalyst for the stock.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now
Previous Story

Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop